Evidence map›Paper›PMID 28670965›Full record

ArticleAIDS research and human retroviruses2017

Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.

Briana A Lynch, Eshan U Patel, Colleen R Courtney, Aubin J Nanfack, Jude Bimela, Xiaohong Wang, Issa Eid, Thomas C Quinn, Oliver Laeyendecker, Phillipe N Nyambi and 2 more

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Briana A Lynch1 Division of Intramural Research, NIAID, NIH , Baltimore, Maryland.
Eshan U Patel2 Department of Pathology, Johns Hopkins University , Baltimore, Maryland.
Colleen R Courtney3 Department of Pathology, New York University , New York, New York.
Aubin J Nanfack4 Medical Diagnostic Center , Yaoundé, Cameroon .
Jude Bimela3 Department of Pathology, New York University , New York, New York.
Xiaohong Wang5 VA Medical Center, New York Harbor Healthcare Systems , New York, New York.
Issa Eid5 VA Medical Center, New York Harbor Healthcare Systems , New York, New York.
Thomas C Quinn1 Division of Intramural Research, NIAID, NIH , Baltimore, Maryland.
Oliver Laeyendecker1 Division of Intramural Research, NIAID, NIH , Baltimore, Maryland.
Phillipe N Nyambi3 Department of Pathology, New York University , New York, New York.
Ralf Duerr3 Department of Pathology, New York University , New York, New York.
Andrew D Redd1 Division of Intramural Research, NIAID, NIH , Baltimore, Maryland.

Funding

LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Laboratory and Statistical Development of Cross-Sectional HIV Incidence AssaysR01AI095068 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2011 to 2021
$6.6M
Training Program on HIV Diversity and Drug Resistance-Enhancing Research CapacityD43TW009604 · FIC · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GORNY, MIROSLAW K · 2013 to 2017
$1.4M
FIC NIH HHS D43 TW009604NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI095068NIAID NIH HHS UM1 AI068613
6 · The paper itself

Abstract

Current serological assays that are used for cross-sectional HIV incidence estimation have been shown to misclassify individuals with chronic infection. Limited information exists on the performance of cross-sectional incidence assays in Central Africa. HIV-positive individuals from Cameroon who were infected for at least 1 or 2 years were evaluated to determine the false recent ratio (FRR) of a two-assay algorithm, which includes the Limiting Antigen Avidity (LAg-Avidity) assay (normalized optical density units, ODn <1.5) and HIV viral load (>1000 copies/ml). The subject-level FRR was 5.3% (95% confidence interval [CI], 2.1-10.5) for individuals infected for ≥1 year and 3.9% (95% CI, 0.8-11.0) for individuals infected for ≥2 years. These data suggest that the LAg-Avidity plus viral load incidence algorithm may overestimate HIV incidence rates in Central Africa.

Indexed as

Diagnostic ErrorsAdultAgedCameroonCross-Sectional StudiesDiagnostic Tests, RoutineFemaleHIV InfectionsHumansImmunoassayIncidenceMaleMiddle AgedViral LoadCamerooncross-sectional incidenceHIV

Identifiers

PMID28670965
PMCPMC5665419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.